SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001103021-21-000128
Filing Date
2021-12-21
Accepted
2021-12-20 20:24:12
Documents
15
Period of Report
2021-12-20
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bdsi-20211220.htm   iXBRL 8-K 45893
2 EX-99.1 bdsi20211220prevailsinbe.htm EX-99.1 5394
6 GRAPHIC bdsi20211220prevailsinbe001.jpg GRAPHIC 276558
7 GRAPHIC bdsi20211220prevailsinbe002.jpg GRAPHIC 49783
  Complete submission text file 0001103021-21-000128.txt   640695

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bdsi-20211220.xsd EX-101.SCH 1878
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bdsi-20211220_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bdsi-20211220_pre.xml EX-101.PRE 12492
9 EXTRACTED XBRL INSTANCE DOCUMENT bdsi-20211220_htm.xml XML 11222
Mailing Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612
Business Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Filer) CIK: 0001103021 (see all company filings)

IRS No.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31361 | Film No.: 211506583
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences